Immix Biopharma (IMMX) Non Operating Income (2021 - 2026)
Immix Biopharma (IMMX) posted Non Operating Income of $913,663 for Q2 2026, up 778.0% from $104,056 a year earlier and up 27.4% from the prior quarter.
Powered by 
Analysis
Immix Biopharma (IMMX) Non Operating Income (2021 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Non Operating Income at Immix Biopharma was $1.93 million, up 177.3% year-over-year; for FY2025, it came in at $555,526, down 45.4% from FY2024.
- In prior years, Immix Biopharma's Non Operating Income was $1.02 million in FY2024 (+77.9%), $572,006 in FY2023, -$497.00 in FY2022 and -$23.03 million in FY2021.
- The Q2 2026 figure stands as the highest quarterly Non Operating Income in data going back to Q1 2021.
- On a year-over-year basis, Non Operating Income has increased in each of the last three quarters, with growth averaging 126.7% over the last eight quarters.
- The strongest year-over-year quarter for Non Operating Income in the past five years was Q1 2024, with growth of 860.5%; the weakest was Q3 2025, with a decline of 67.1%.
- According to Business Quant data, Non Operating Income for the three prior quarters was $717,168 (Q1 2026), $216,712 (Q4 2025) and $84,539 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Immix Biopharma | 743.97 Mn | 743.97 Mn | - | 913,663.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 913,663.00 |
| Mar 31, 2026 | 717,168.00 |
| Dec 31, 2025 | 216,712.00 |
| Sep 30, 2025 | 84,539.00 |
| Jun 30, 2025 | 104,056.00 |
| Mar 31, 2025 | 150,219.00 |
| Dec 31, 2024 | 185,851.00 |
| Sep 30, 2024 | 256,680.00 |
| Jun 30, 2024 | 306,915.00 |
| Mar 31, 2024 | 267,908.00 |
| Dec 31, 2023 | 228,575.00 |
| Sep 30, 2023 | 186,691.00 |
| Jun 30, 2023 | 128,848.00 |
| Mar 31, 2023 | 27,892.00 |
| Jun 30, 2022 | -109.00 |
| Mar 31, 2022 | -388.00 |
| Dec 31, 2021 | -22.16 Mn |
| Sep 30, 2021 | -53,937.00 |
| Jun 30, 2021 | -36,135.00 |
| Mar 31, 2021 | -852,544.00 |
API Access
Immix Biopharma Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=IMMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "IMMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=IMMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();